Overview
Jinjin Hao practices practicing medicine in Wuhan, China.
Their clinical expertise encompasses Acute Megakaryoblastic Leukemia, Acute Lymphoblastic Leukemia (ALL), and Leukemia.
They are actively involved in clinical research, co-authoring 11 peer reviewed articles.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Jinjin Hao
Is Jinjin Hao a top-rated expert for Acute Megakaryoblastic Leukemia?
MediFind is an objective health platform that identifies experts based on real-world data. Jinjin Hao is classified as an Experienced expert for Acute Megakaryoblastic Leukemia, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Jinjin Hao participate in research or clinical trials?
Yes. Jinjin Hao has published 11 articles and abstracts on conditions like Acute Megakaryoblastic Leukemia. You can view a list of Jinjin Hao's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- Acute Lymphoblastic Leukemia (ALL)
- Acute Megakaryoblastic Leukemia
- LeukemiaHao isExperienced. Learn about Leukemia.